These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
318 related items for PubMed ID: 11784934
41. Long-term efficacy of 2 year WHO multiple drug therapy (MDT) in multibacillary (MB) leprosy patients. Cellona RV, Balagon MF, dela Cruz EC, Burgos JA, Abalos RM, Walsh GP, Topolski R, Gelber RH, Walsh DS. Int J Lepr Other Mycobact Dis; 2003 Dec; 71(4):308-19. PubMed ID: 14763888 [Abstract] [Full Text] [Related]
42. Detection of Mycobacterium leprae DNA by PCR in blood sample from nine-banded armadillo: preliminary results. Deps PD, Santos AR, Yamashita-Tomimori J. Int J Lepr Other Mycobact Dis; 2002 Mar; 70(1):34-5. PubMed ID: 12120038 [No Abstract] [Full Text] [Related]
43. A study on the effectiveness and safety of the WHO/MDT regimen in the northeast of Thailand; a prospective study, 1984-1996. Dasananjali K, Schreuder PA, Pirayavaraporn C. Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):28-36. PubMed ID: 9207751 [Abstract] [Full Text] [Related]
52. Mycobacterium leprae DNA associated with type 1 reactions in single lesion paucibacillary leprosy treated with single dose rifampin, ofloxacin, and minocycline. Sousa AL, Stefani MM, Pereira GA, Costa MB, Rebello PF, Gomes MK, Narahashi K, Gillis TP, Krahenbuhl JL, Martelli CM. Am J Trop Med Hyg; 2007 Nov; 77(5):829-33. PubMed ID: 17984336 [Abstract] [Full Text] [Related]
53. Relapses in leprosy patients treated with rifampicin plus dapsone after varying periods of dapsone monotherapy. Li HY, Ran SP, Weng XM, Li TG, Deng XH, Li FT. Indian J Lepr; 2001 Nov; 73(1):1-10. PubMed ID: 11326592 [Abstract] [Full Text] [Related]
54. Childhood leprosy in a tertiary-care hospital in Delhi, India: a reappraisal in the post-elimination era. Singal A, Sonthalia S, Pandhi D. Lepr Rev; 2011 Sep; 82(3):259-69. PubMed ID: 22125934 [Abstract] [Full Text] [Related]
57. Long-term relapse risk of multibacillary leprosy after completion of 2 years of multiple drug therapy (WHO-MDT) in Cebu, Philippines. Balagon MF, Cellona RV, Cruz Ed, Burgos JA, Abalos RM, Walsh GP, Saunderson PR, Walsh DS. Am J Trop Med Hyg; 2009 Nov; 81(5):895-9. PubMed ID: 19861628 [Abstract] [Full Text] [Related]
58. Combined 12-month WHO/MDT MB regimen and Mycobacterium w. vaccine in multibacillary leprosy: a follow-up of 136 patients. Kaur I, Dogra S, Kumar B, Radotra BD. Int J Lepr Other Mycobact Dis; 2002 Sep; 70(3):174-81. PubMed ID: 12483965 [Abstract] [Full Text] [Related]
59. qPCR-High resolution melt analysis for drug susceptibility testing of Mycobacterium leprae directly from clinical specimens of leprosy patients. Araujo S, Goulart LR, Truman RW, Goulart IMB, Vissa V, Li W, Matsuoka M, Suffys P, Fontes AB, Rosa PS, Scollard DM, Williams DL. PLoS Negl Trop Dis; 2017 Jun; 11(6):e0005506. PubMed ID: 28570560 [Abstract] [Full Text] [Related]
60. Susceptibility to leprosy may be conditioned by an interaction between the NRAMP1 promoter polymorphisms and the lepromin response. Ferreira FR, Goulart LR, Silva HD, Goulart IM. Int J Lepr Other Mycobact Dis; 2004 Dec; 72(4):457-67. PubMed ID: 15755200 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]